Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Celcuity Inc (NQ: CELC ) 15.50 -0.36 (-2.27%) Official Closing Price Updated: 4:15 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Celcuity Inc < Previous 1 2 3 4 Next > Celcuity to Participate in the William Blair Biotech Focus Conference July 08, 2021 MINNEAPOLIS, MN / ACCESSWIRE / July 8, 2021 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating... From Celcuity Inc. Via AccessWire 58 Biggest Movers From Yesterday June 30, 2021 Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors.... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Intraday Session June 29, 2021 Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock moved upwards by 93.55% to $24.33 during Tuesday's regular session. As of 12:30 EST, this security is trading at... Via Benzinga 35 Stocks Moving In Tuesday's Mid-Day Session June 29, 2021 Gainers Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) shares jumped 111.5% to $26.58 after the company announced positive results from its Phase 1b clinical trial of CVL-231... Via Benzinga Why Celcuity Stock Is Crashing Today June 29, 2021 The clinical-stage biotech announced the pricing of a secondary stock offering. Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 29, 2021 Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) shares moved upwards by 42.0% to $17.85 during Tuesday's pre-market session. The company's market cap stands at $2.... Via Benzinga 22 Stocks Moving in Tuesday's Pre-Market Session June 29, 2021 Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to... Via Benzinga Celcuity Announces Pricing of Follow-on Offering June 28, 2021 MINNEAPOLIS, MN / ACCESSWIRE / June 28, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating... From Celcuity Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory 12 Health Care Stocks Moving In Monday's After-Market Session June 28, 2021 Gainers SCWorx (NASDAQ:WORX) shares rose ... Via Benzinga Celcuity Announces Launch of Follow-on Offering June 28, 2021 MINNEAPOLIS, MN / ACCESSWIRE / June 28, 2021 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating... From Celcuity Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs June 25, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... Via Benzinga Exposures COVID-19 45 Biggest Movers From Yesterday June 25, 2021 Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads... Via Benzinga Celcuity Announces Appointment of Dr. Igor Gorbatchevsky as VP of Clinical Development and Jill Krause as VP of Clinical Operations June 09, 2021 MINNEAPOLIS, MN / ACCESSWIRE / June 9, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating... From Celcuity Inc. Via AccessWire Exposures COVID-19 Product Safety The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq May 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,... Via Benzinga Exposures Product Safety Celcuity Inc. Reports First Quarter 2021 Financial Results and Provides Corporate Update May 10, 2021 - Entered into worldwide licensing agreement with Pfizer to develop and commercialize gedatolisib, a first-in-class PI3K/mTOR inhibitor, in clinical development for breast cancer - Announced... From Celcuity Inc. Via AccessWire Exposures COVID-19 Product Safety Celcuity Inc. Schedules Release of First Quarter 2021 Financial Results and Webcast April 26, 2021 MINNEAPOLIS, MN / ACCESSWIRE / April 26, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic (CDx) and therapeutic strategy for... From Celcuity Inc. Via AccessWire Exposures COVID-19 The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx April 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... Via Benzinga Celcuity Presents Data at AACR Annual Meeting Assessing Gedatolisib, a pan-PI3K/mTOR Inhibitor, in HER2-negative Breast and Ovarian Cancer Patient Tumors with Hyperactive RAS Network Signaling April 12, 2021 - Inhibition of hyperactive RAS network signaling is nine times more effective with gedatolisib than with a PI3K-α inhibitor - - Synergistic cooperation between PI3K/mTOR and BCL signaling detected,... From Celcuity Inc. Via AccessWire Exposures COVID-19 Product Safety The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping April 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... Via Benzinga Exposures Product Safety What's Happening With ATNF Stock And CELC Stock? April 12, 2021 180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher following insider buying from Marc Feldmann, a director on the company's board, and Jonathan Rothbard, the... Via Benzinga 42 Stocks Moving In Monday's Mid-Day Session April 12, 2021 Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake... Via Benzinga The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout April 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Mid-Afternoon Market Update: Dow Surges Over 100 Points; Provention Bio Shares Plunge April 09, 2021 Toward the end of trading Friday, the Dow traded up 0.42% to 33,645.90 while the NASDAQ rose 0.06% to 13,837.33. The S&P also rose, gaining 0.32% to 4,110.11. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead April 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (... Via Benzinga Exposures Product Safety Mid-Day Market Update: WD-40 Drops After Weak Q2 Results; Celcuity Shares Jump April 09, 2021 Midway through trading Friday, the Dow traded up 0.28% to 33,598.84 while the NASDAQ fell 0.16% to 13,806.77. The S&P also rose, gaining 0.13% to 4,102.64. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug April 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (... Via Benzinga Exposures Product Safety 55 Biggest Movers From Yesterday April 13, 2021 Gainers Celcuity Inc. (NASDAQ: CELC) jumped 29.4% to settle at $27.94. Celcuity shares climbed 51% on Friday after the company announced a worldwide licensing agreement with... Via Benzinga 51 Biggest Movers From Friday April 12, 2021 Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
